Idan Goren

1.5k total citations
51 papers, 653 citations indexed

About

Idan Goren is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Idan Goren has authored 51 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 21 papers in Epidemiology and 16 papers in Surgery. Recurrent topics in Idan Goren's work include Inflammatory Bowel Disease (29 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (6 papers). Idan Goren is often cited by papers focused on Inflammatory Bowel Disease (29 papers), Microscopic Colitis (14 papers) and Eosinophilic Esophagitis (6 papers). Idan Goren collaborates with scholars based in Israel, United States and United Kingdom. Idan Goren's co-authors include Iris Dotan, Henit Yanai, Gad Segal, Hagit Tulchinsky, Lihi Godny, Uri Gophna, Yehuda Shoenfeld, Roni Weisshof, Lea Reshef and Yehuda Chowers and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Gut.

In The Last Decade

Idan Goren

47 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Idan Goren Israel 13 407 250 151 142 139 51 653
Roni Weisshof United States 14 551 1.4× 376 1.5× 192 1.3× 148 1.0× 116 0.8× 30 794
Liliana Łykowska‐Szuber Poland 16 320 0.8× 206 0.8× 155 1.0× 97 0.7× 132 0.9× 51 663
Sudheer K. Vuyyuru India 14 391 1.0× 289 1.2× 238 1.6× 81 0.6× 147 1.1× 84 759
Linda Ceccarelli Italy 12 301 0.7× 234 0.9× 191 1.3× 129 0.9× 74 0.5× 29 598
Orlaith Kelly Ireland 12 396 1.0× 302 1.2× 267 1.8× 113 0.8× 186 1.3× 41 767
Manuel Martínez-Vazquez Mexico 12 280 0.7× 249 1.0× 118 0.8× 112 0.8× 51 0.4× 30 524
Azza Filali Tunisia 16 368 0.9× 273 1.1× 277 1.8× 115 0.8× 82 0.6× 106 713
Ray Boyapati Australia 12 410 1.0× 303 1.2× 286 1.9× 233 1.6× 282 2.0× 37 942
Sawan Bopanna India 19 465 1.1× 307 1.2× 471 3.1× 81 0.6× 170 1.2× 44 953
Abbi R. Saniabadi Japan 16 554 1.4× 367 1.5× 189 1.3× 316 2.2× 68 0.5× 30 842

Countries citing papers authored by Idan Goren

Since Specialization
Citations

This map shows the geographic impact of Idan Goren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Idan Goren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Idan Goren more than expected).

Fields of papers citing papers by Idan Goren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Idan Goren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Idan Goren. The network helps show where Idan Goren may publish in the future.

Co-authorship network of co-authors of Idan Goren

This figure shows the co-authorship network connecting the top 25 collaborators of Idan Goren. A scholar is included among the top collaborators of Idan Goren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Idan Goren. Idan Goren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Massey, William J., Jiannan Li, Idan Goren, Ilyssa O. Gordon, & Florian Rieder. (2024). NON-CASEATING GRANULOMAS ARE ASSOCIATED WITH STRICTURING CROHN’S DISEASE AND THEIR NUMBER AND SIZE ARE INCREASED IN THE MUSCULARIS PROPRIA OF STRICTURED COMPARED TO NON-STRICTURED INTESTINGAL SEGMENTS. Inflammatory Bowel Diseases. 30(Supplement_1). S61–S61. 1 indexed citations
2.
Massey, William J., et al.. (2024). Muscular hyperplasia in Crohn’s disease strictures: through thick and thin. American Journal of Physiology-Cell Physiology. 327(3). C671–C683. 2 indexed citations
3.
Yerushalmy‐Feler, Anat, Yiska Loewenberg Weisband, Shira Greenfeld, et al.. (2024). Peripheral Blood Eosinophilia at Diagnosis of Inflammatory Bowel Disease Is Associated With Severe Disease Course: A Nationwide Study From the epi-IIRN Cohort. Journal of Crohn s and Colitis. 19(2). 1 indexed citations
5.
Atia, Ohad, Idan Goren, Shira Greenfeld, et al.. (2023). 5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study. Alimentary Pharmacology & Therapeutics. 57(9). 1004–1013. 12 indexed citations
6.
Atia, Ohad, Shira Greenfeld, Revital Kariv, et al.. (2023). Prevalence and Outcomes of No Treatment Versus 5-ASA in Ulcerative Colitis: A Nationwide Analysis From the epi-IIRN. Inflammatory Bowel Diseases. 30(2). 213–221. 6 indexed citations
7.
Yanai, Henit, Idan Goren, Jacob E. Ollech, et al.. (2023). A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes. Crohn s & Colitis 360. 5(4). otad064–otad064. 2 indexed citations
8.
Atia, Ohad, Idan Goren, Yiska Loewenberg Weisband, et al.. (2023). P467 5-ASA is not superior to no-maintenance in patients with newly diagnosed Crohn’s disease - a nationwide cohort from the epi-IIRN. Journal of Crohn s and Colitis. 17(Supplement_1). i596–i596. 1 indexed citations
9.
Ouali, Sara El, Mark E. Baker, Cathy Lu, et al.. (2023). Tu1787 VEDOLIZUMAB AS A MEDICAL THERAPY FOR SYMPTOMATIC STRICTURING SMALL BOWEL CROHN'S DISEASE - RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT STUDY. Gastroenterology. 164(6). S–1128. 1 indexed citations
10.
Konikoff, Tom, Idan Goren, Irit Avni‐Biron, et al.. (2021). Machine learning for selecting patients with Crohn's disease for abdominopelvic computed tomography in the emergency department. Digestive and Liver Disease. 53(12). 1559–1564. 6 indexed citations
11.
Verstockt, Bram, Davide Giuseppe Ribaldone, Iván Guerra, et al.. (2021). Diagnosis and Outcome of Extranodal Primary Intestinal Lymphoma in Inflammatory Bowel Disease: An ECCO CONFER Case Series. Journal of Crohn s and Colitis. 16(3). 500–505. 7 indexed citations
12.
Banerjee, Rupa, et al.. (2020). NUDT15 C415T variant compared with TPMT genotyping in predicting azathioprine‐induced leucopenia: prospective analysis of 1014 inflammatory bowel disease patients in India. Alimentary Pharmacology & Therapeutics. 52(11-12). 1683–1694. 28 indexed citations
13.
Schmilovitz‐Weiss, Hemda, Doron Boltin, David Groshar, et al.. (2020). [¹¹C] choline as a potential PET/CT biomarker of liver cirrhosis: A prospective pilot study. Digestive and Liver Disease. 53(6). 753–759. 1 indexed citations
14.
Godny, Lihi, Lea Reshef, Tamar Pfeffer‐Gik, et al.. (2019). Adherence to the Mediterranean diet is associated with decreased fecal calprotectin in patients with ulcerative colitis after pouch surgery. European Journal of Nutrition. 59(7). 3183–3190. 69 indexed citations
15.
Goren, Idan, Adi Brom, Henit Yanai, et al.. (2019). Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9‐year cohort study. United European Gastroenterology Journal. 8(2). 195–203. 11 indexed citations
16.
Ben‐Shachar, Shay, Keren M. Rabinowitz, Idan Goren, et al.. (2018). Genotype–Serotype Interactions Shed Light on Genetic Components of Inflammatory Bowel Diseases. Inflammatory Bowel Diseases. 25(2). 336–344. 2 indexed citations
17.
Tanné, David, et al.. (2017). Classical and additional antiphospholipid antibodies in blood samples of ischemic stroke patients and healthy controls. Immunologic Research. 65(2). 470–476. 4 indexed citations
18.
Goren, Idan, Ariel Israel, Narin N. Carmel Neiderman, et al.. (2016). Vomiting and Hyponatremia Are Risk Factors for Worse Clinical Outcomes Among Patients Hospitalized Due to Nonsurgical Abdominal Pain. Medicine. 95(14). e3274–e3274.
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026